Lipoprotein glomerulopathy induced by ApoE Kyoto mutation in ApoE-deficient mice.

ApoE Kyoto (p.R43C) ApoE Sendai (p.R163P) Atherosclerosis Lipoprotein glomerulopathy Recombinant adenovirus

Journal

Journal of translational medicine
ISSN: 1479-5876
Titre abrégé: J Transl Med
Pays: England
ID NLM: 101190741

Informations de publication

Date de publication:
04 03 2021
Historique:
received: 01 10 2020
accepted: 22 02 2021
entrez: 5 3 2021
pubmed: 6 3 2021
medline: 15 5 2021
Statut: epublish

Résumé

Lipoprotein glomerulopathy (LPG) is a rare autosomal dominant kidney disease that is most commonly caused by mutations in ApoE Kyoto (p.R43C) and ApoE Sendai (p.R163P). Differences in phenotype among the various ApoE mutations have been suggested, but the pathogenic role of ApoE Kyoto has not been validated in an animal model. This study intended to establish an ApoE Kyoto murine model and to further compare the pathologic differences between ApoE Kyoto and ApoE Sendai. Male ApoE-deficient mice, 3 months of age, were divided into five groups, including the AD-ApoE Sendai, AD-ApoE Kyoto, AD-ApoE3, AD-eGFP, and ApoE (-/-) groups. The first four groups received recombinant adenovirus that contained the entire coding regions of the human ApoE Sendai and ApoE Kyoto, apoE3, and eGFP genes, respectively. Fasting blood and urine samples were collected at multiple time points. Lipid profiles and urine albumin-creatinine ratio were measured. Renal and aortic histopathologic alterations were analyzed. After virus injection, plasma human ApoE was detected and rapidly reached the maximum level at 4-6 days in the AD-ApoE Kyoto and AD-ApoE Sendai groups (17.4 ± 3.1 µg/mL vs.: 22.2 ± 4.5 µg/mL, respectively) and at 2 days in the AD-ApoE3 group (38.4 µg/mL). The serum total cholesterol decreased by 63%, 65%, and 73% in the AD-ApoE Kyoto, AD-ApoE Sendai and AD-ApoE3 groups, respectively. There were no significant changes in serum triglyceride and urinary albumin-creatinine ratio among the five groups. Typical lipoprotein thrombi with positive ApoE staining were detected in the AD-ApoE Kyoto and AD-ApoE Sendai groups. The Oil-red O-positive glomerular area tended to be higher in the AD-ApoE Kyoto group (9.2%) than in the AD-ApoE Sendai (3.9%), AD-ApoE3 (4.8%), AD-eGFP (2.9%), and ApoE (-/-) (3.6%) groups. The atherosclerotic plaque area in the aorta was lower in the group injected with various ApoE mutations than in the group without injection of ApoE mutation. In this animal study, we first established an ApoE Kyoto mutation murine model and confirmed its pathogenic role in LPG. Our results suggested that LPG may be more severe with the ApoE Kyoto than with the ApoE Sendai.

Sections du résumé

BACKGROUND
Lipoprotein glomerulopathy (LPG) is a rare autosomal dominant kidney disease that is most commonly caused by mutations in ApoE Kyoto (p.R43C) and ApoE Sendai (p.R163P). Differences in phenotype among the various ApoE mutations have been suggested, but the pathogenic role of ApoE Kyoto has not been validated in an animal model. This study intended to establish an ApoE Kyoto murine model and to further compare the pathologic differences between ApoE Kyoto and ApoE Sendai.
METHOD
Male ApoE-deficient mice, 3 months of age, were divided into five groups, including the AD-ApoE Sendai, AD-ApoE Kyoto, AD-ApoE3, AD-eGFP, and ApoE (-/-) groups. The first four groups received recombinant adenovirus that contained the entire coding regions of the human ApoE Sendai and ApoE Kyoto, apoE3, and eGFP genes, respectively. Fasting blood and urine samples were collected at multiple time points. Lipid profiles and urine albumin-creatinine ratio were measured. Renal and aortic histopathologic alterations were analyzed.
RESULTS
After virus injection, plasma human ApoE was detected and rapidly reached the maximum level at 4-6 days in the AD-ApoE Kyoto and AD-ApoE Sendai groups (17.4 ± 3.1 µg/mL vs.: 22.2 ± 4.5 µg/mL, respectively) and at 2 days in the AD-ApoE3 group (38.4 µg/mL). The serum total cholesterol decreased by 63%, 65%, and 73% in the AD-ApoE Kyoto, AD-ApoE Sendai and AD-ApoE3 groups, respectively. There were no significant changes in serum triglyceride and urinary albumin-creatinine ratio among the five groups. Typical lipoprotein thrombi with positive ApoE staining were detected in the AD-ApoE Kyoto and AD-ApoE Sendai groups. The Oil-red O-positive glomerular area tended to be higher in the AD-ApoE Kyoto group (9.2%) than in the AD-ApoE Sendai (3.9%), AD-ApoE3 (4.8%), AD-eGFP (2.9%), and ApoE (-/-) (3.6%) groups. The atherosclerotic plaque area in the aorta was lower in the group injected with various ApoE mutations than in the group without injection of ApoE mutation.
CONCLUSIONS
In this animal study, we first established an ApoE Kyoto mutation murine model and confirmed its pathogenic role in LPG. Our results suggested that LPG may be more severe with the ApoE Kyoto than with the ApoE Sendai.

Identifiants

pubmed: 33663537
doi: 10.1186/s12967-021-02765-x
pii: 10.1186/s12967-021-02765-x
pmc: PMC7934380
doi:

Substances chimiques

Apolipoproteins E 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

97

Références

J Am Soc Nephrol. 2002 Jun;13(6):1527-33
pubmed: 12039982
Kidney Int. 2020 Feb;97(2):279-288
pubmed: 31874799
J Atheroscler Thromb. 2011;18(6):531-5
pubmed: 21325775
Atherosclerosis. 2009 May;204(1):121-6
pubmed: 18930458
Nephrol Dial Transplant. 2012 Oct;27(10):3899-907
pubmed: 22863838
Kidney Int. 1999 Aug;56(2):421-7
pubmed: 10432380
J Biol Chem. 1982 Apr 25;257(8):4171-8
pubmed: 7068630
Mol Genet Genomic Med. 2020 Aug;8(8):e1281
pubmed: 32441489
Clin Exp Nephrol. 2014 Apr;18(2):220-4
pubmed: 24570178
J Lipid Res. 2013 Jan;54(1):164-76
pubmed: 23110818
J Lipid Res. 2018 Dec;59(12):2339-2348
pubmed: 30309894
J Atheroscler Thromb. 2011;18(6):542-3
pubmed: 21670560
Clin Exp Nephrol. 2014 Apr;18(2):214-7
pubmed: 24149835
Arterioscler Thromb Vasc Biol. 2006 Aug;26(8):1852-7
pubmed: 16763161
J Am Soc Nephrol. 1997 May;8(5):820-3
pubmed: 9176854
Kidney Int. 2014 Feb;85(2):416-24
pubmed: 24025644
J Biol Chem. 2000 Oct 6;275(40):31269-73
pubmed: 10903326
Metabolism. 2002 Feb;51(2):201-5
pubmed: 11833049
J Lipid Res. 2014 Oct;55(10):2073-81
pubmed: 25183802
J Atheroscler Thromb. 2018 Aug 1;25(8):733-740
pubmed: 29398675
J Atheroscler Thromb. 2011;18(6):536-41
pubmed: 21467726

Auteurs

Hongyan Wu (H)

Department of Nephrology and National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Sichuan, Guoxue Alley, 37#, Wuhou District, Chengdu, 610041, China.

Jing Yang (J)

Department of Nephrology and National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Sichuan, Guoxue Alley, 37#, Wuhou District, Chengdu, 610041, China.

Yun-Qiang Liu (YQ)

Department of Medical Genetics, West China Hospital, Sichuan University, Chengdu, China.

Song Lei (S)

Department of Pathology, West China Hospital, Sichuan University, Chengdu, China.

Mei Yang (M)

Department of Pathology, West China Hospital, Sichuan University, Chengdu, China.

Zhi Yang (Z)

Department of Nephrology and National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Sichuan, Guoxue Alley, 37#, Wuhou District, Chengdu, 610041, China.

Yuan Yang (Y)

Department of Medical Genetics, West China Hospital, Sichuan University, Chengdu, China.

Zhangxue Hu (Z)

Department of Nephrology and National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Sichuan, Guoxue Alley, 37#, Wuhou District, Chengdu, 610041, China. hzxawy@scu.edu.cn.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH